Kidney Transplant Research Today is a free monthly online journal that collates and summarizes the latest research about Kidney Transplant, including details on risks, prognosis, procedure, surgery, organ donation.

Volume 2 (2005), Issue 3 (March)

1. Mycophenolate mofetil vs. azathioprine is associated with decreased acute rejection, late acute rejection, and risk for cardiovascular death in renal transplant recipients with pre-transplant diabetes.
   Clin Transplant, 19(2): 279-85. [Abstract] [Full-text]
2. Cytomegalovirus prophylaxis with valganciclovir in African-American renal allograft recipients based on donor/recipient serostatus.
   Clin Transplant, 19(2): 273-8. [Abstract] [Full-text]
3. Limitations of glomerular filtration rate equations in the renal transplant patient.
   Clin Transplant, 19(2): 259-68. [Abstract] [Full-text]
4. Rapamycin in patients with chronic renal allograft dysfunction.
   Clin Transplant, 19(2): 236-42. [Abstract] [Full-text]
5. Urinary tract infections after renal transplantation: a retrospective review at two US transplant centers.
   Clin Transplant, 19(2): 230-5. [Abstract] [Full-text]
6. Basiliximab lowers the cyclosporine therapeutic threshold in the early post-kidney transplant period.
   Clin Transplant, 19(2): 225-9. [Abstract] [Full-text]
7. Hypertension, antihypertensive agents and outcomes following renal transplantation.
   Clin Transplant, 19(2): 181-92. [Abstract] [Full-text]
8. Effects of mycophenolate mofetil on donor-specific antibody formation in renal transplantation.
   Clin Transplant, 19(2): 168-74. [Abstract] [Full-text]
9. The effect of sirolimus on sex hormone levels of male renal transplant recipients.
   Clin Transplant, 19(2): 162-7. [Abstract] [Full-text]
10. Greater early pancreas graft loss in women compared with men after simultaneous pancreas-kidney transplantation.
    Clin Transplant, 19(2): 158-61. [Abstract] [Full-text]
11. The long-term outcome of tacrolimus in cadaveric kidney transplantation from non-heart beating donors.
    Clin Transplant, 19(2): 153-7. [Abstract] [Full-text]
12. Therapeutic drug monitoring for everolimus in kidney transplantation using 12-month exposure, efficacy, and safety data.
    Clin Transplant, 19(2): 145-52. [Abstract] [Full-text]
13. Central nervous system vasculitis secondary to parvovirus B19 infection in a pediatric renal transplant patient.
    Pediatr Nephrol, 20(4): 529-33. [Abstract] [Full-text]
14. Randomized prospective trial of early steroid withdrawal compared with low-dose steroids in renal transplant recipients using serial protocol biopsies to assess efficacy and safety.
    Surgery, 137(3): 364-71. [Abstract] [Full-text]
15. A simplified strategy for clinical management of late cytomegalovirus infection after oral ganciclovir prophylaxis in renal recipients.
    J Antimicrob Chemother, 55(3): 391-4. [Abstract] [Full-text]
16. Informed consent in renal transplantation.
    Postgrad Med J, 81(953): 188-90. [Abstract] [Full-text]
17. The Renal Treatment Satisfaction Questionnaire (RTSQ): a measure of satisfaction with treatment for chronic kidney failure.
    Am J Kidney Dis, 45(3): 572-9. [Abstract] [Full-text]
18. Skin carcinoma arising from donor cells in a kidney transplant recipient.
    Cancer Res, 65(5): 1755-60. [Abstract] [Full-text]
19. Posttransplant symptomatic lymphocele treatment with percutaneous drainage and ethanol sclerosis: long-term follow-up.
    Clin Imaging, 29(2): 109-16. [Abstract] [Full-text]
20. Mycophenolic acid pharmacokinetics and related outcomes early after renal transplant.
    Br J Clin Pharmacol, 59(3): 271-80. [Abstract] [Full-text]
21. Analytical approaches for transplant research, 2004.
    Am J Transplant, 5(4): 950-7. [Abstract] [Full-text]
22. Current status of kidney and pancreas transplantation in the United States, 1994-2003.
    Am J Transplant, 5(4): 904-15. [Abstract] [Full-text]
23. Successful liver and kidney transplantation from cadaveric donors with left-sided bacterial endocarditis.
    Am J Transplant, 5(4): 781-7. [Abstract] [Full-text]
24. Analysis of factors that influence survival with post-transplant lymphoproliferative disorder in renal transplant recipients: the Israel Penn International Transplant Tumor Registry experience.
    Am J Transplant, 5(4): 775-80. [Abstract] [Full-text]
25. Vascular endothelial growth factor expression and cyclosporine toxicity in renal allograft rejection.
    Am J Transplant, 5(4): 766-74. [Abstract] [Full-text]
26. The broad spectrum of quality in deceased donor kidneys.
    Am J Transplant, 5(4): 757-65. [Abstract] [Full-text]
27. Evaluation of T-cell receptor repertoires in patients with long-term renal allograft survival.
    Am J Transplant, 5(4): 746-56. [Abstract] [Full-text]
28. Retroperitoneoscopic live donor nephrectomy (RPLDN): establishment and initial experience of RPLDN at a single center.
    Am J Transplant, 5(4): 739-45. [Abstract] [Full-text]
29. Proteomic-based identification of cleaved urinary beta2-microglobulin as a potential marker for acute tubular injury in renal allografts.
    Am J Transplant, 5(4): 729-38. [Abstract] [Full-text]
30. Long-term prospective study of steroid withdrawal in kidney and heart transplant recipients.
    Am J Transplant, 5(4): 720-8. [Abstract] [Full-text]
31. Selectin blockade plus therapy with low-dose sirolimus and cyclosporin a prevent brain death-induced renal allograft dysfunction.
    Am J Transplant, 5(4): 662-70. [Abstract] [Full-text]
32. Vascular and nonvascular complications of renal transplants: sonographic evaluation and correlation with other imaging modalities, surgery, and pathology.
    J Clin Ultrasound, 33(3): 127-39. [Abstract] [Full-text]
33. Risk factors for gingival overgrowth in patients medicated with ciclosporin in the absence of calcium channel blockers.
    J Clin Periodontol, 32(3): 273-9. [Abstract] [Full-text]
34. Review article: hepatitis C virus infection and type-2 diabetes mellitus in renal diseases and transplantation.
    Aliment Pharmacol Ther, 21(6): 623-32. [Abstract] [Full-text]
35. Life after transplantation: new transitions in quality of life and psychological distress.
    Semin Dial, 18(2): 124-31. [Abstract] [Full-text]
36. Macrophage-derived interleukin-18 in experimental renal allograft rejection.
    Nephrol Dial Transplant, 20(4): 699-706. [Abstract] [Full-text]
37. Persistent cytomegalovirus infection is associated with increased expression of TGF-beta1, PDGF-AA and ICAM-1 and arterial intimal thickening in kidney allografts.
    Nephrol Dial Transplant, 20(4): 790-6. [Abstract] [Full-text]
38. Tuberculosis in renal transplant recipients on various immunosuppressive regimens.
    Nephrol Dial Transplant, 20(4): 797-802. [Abstract] [Full-text]
39. Gender imbalance among donors in living kidney transplantation: the Norwegian experience.
    Nephrol Dial Transplant, 20(4): 783-9. [Abstract] [Full-text]
40. Antibodies against mesangial cells in a rat model of chronic renal allograft rejection.
    Nephrol Dial Transplant, 20(4): 692-8. [Abstract] [Full-text]
41. Clinical outcomes and C2 cyclosporin monitoring in maintenance renal transplant recipients: 1 year follow-up study.
    Nephrol Dial Transplant, 20(4): 803-10. [Abstract] [Full-text]
42. Papillary necrosis causing hydronephrosis in renal allograft treated by percutaneous retrieval of sloughed papilla.
    Br J Radiol, 78(928): 346-8. [Abstract] [Full-text]
43. Rosiglitazone is a safe and effective treatment option of new-onset diabetes mellitus after renal transplantation.
    Transpl Int, 18(4): 483-6. [Abstract] [Full-text]
44. A cluster of rotavirus enteritis in adult transplant recipients.
    Transpl Int, 18(4): 470-4. [Abstract] [Full-text]
45. Unusual post-transplantation recurrence of focal segmental glomerulosclerosis which resolved with cyclosporine but not with sirolimus.
    Transpl Int, 18(4): 458-60. [Abstract] [Full-text]
46. Long-term follow-up of double kidney transplantation using a score for evaluation of marginal donors*.
    Transpl Int, 18(4): 453-7. [Abstract] [Full-text]
47. A comparative study of resource use and costs of renal, liver and heart transplantation.
    Transpl Int, 18(4): 437-43. [Abstract] [Full-text]
48. Long-term results of a prospective randomized trial comparing tacrolimus versus cyclosporine in African-American recipients of primary cadaver renal transplant.
    Transpl Int, 18(4): 419-22. [Abstract] [Full-text]
49. Potential value of high-dose mizoribine as rescue therapy for ongoing acute humoral rejection.
    Transpl Int, 18(4): 401-7. [Abstract] [Full-text]
50. Influence of kidney function to the impact of acute rejection on long-term kidney transplant survival.
    Transpl Int, 18(4): 385-9. [Abstract] [Full-text]
51. Assessing the relative risk of cardiovascular disease among renal transplant patients receiving tacrolimus or cyclosporine.
    Transpl Int, 18(4): 379-84. [Abstract] [Full-text]
52. Thyroid cancer in the renal transplant population: epidemiological study.
    ANZ J Surg, 75(3): 106-9. [Abstract] [Full-text]
53. The kidney bridge procedure for bilateral ureteral loss.
    Urology, 65(3): 591. [Abstract] [Full-text]
54. Safety and success of kidney transplantation and concomitant immunosuppression in HIV-positive patients.
    Kidney Int, 67(4): 1622-9. [Abstract] [Full-text]
55. BCA-1/CXCL13 expression is associated with CXCR5-positive B-cell cluster formation in acute renal transplant rejection.
    Kidney Int, 67(4): 1616-21. [Abstract] [Full-text]
56. Evaluation of pre-implantation kidney biopsies: comparison of Banff criteria to a morphometric approach.
    Kidney Int, 67(4): 1595-600. [Abstract] [Full-text]
57. Lectin-like oxidized low-density lipoprotein (LDL) receptor (LOX-1)-mediated pathway and vascular oxidative injury in older-age rat renal transplants.
    Kidney Int, 67(4): 1583-94. [Abstract] [Full-text]
58. Renography within 1 hour of renal transplantation: technical feasibility and clinical utility.
    Med Princ Pract, 14(2): 111-4. [Abstract] [Full-text]
59. Transmission of rabies virus from an organ donor to four transplant recipients.
    N Engl J Med, 352(11): 1103-11. [Abstract] [Full-text]
60. Atorvastatin does not affect the pharmacokinetics of cyclosporine in renal transplant recipients.
    Eur J Clin Pharmacol, 61(1): 59-62. [Abstract] [Full-text]
61. An unusual case of pyelonephritis in a pediatric renal transplant recipient.
    Pediatr Transplant, 9(2): 258-60. [Abstract] [Full-text]
62. A prospective trial of steroid withdrawal after renal transplantation treated with cyclosporine and mizoribine in children: results obtained between 1990 and 2003.
    Pediatr Transplant, 9(2): 232-8. [Abstract] [Full-text]
63. Primary focal segmental glomerulosclerosis--long-term outcome after pediatric renal transplantation.
    Pediatr Transplant, 9(2): 226-31. [Abstract] [Full-text]
64. Seroprevalence of antibodies against varicella-zoster virus and response to the varicella vaccine in pediatric renal transplant patients.
    Pediatr Transplant, 9(2): 192-6. [Abstract] [Full-text]
65. Invasive pneumococcal disease in pediatric organ transplant recipients: a high-risk population.
    Pediatr Transplant, 9(2): 183-6. [Abstract] [Full-text]
66. Improved long-term allograft function in pediatric renal transplantation with mycophenolate mofetil.
    Pediatr Transplant, 9(2): 178-82. [Abstract] [Full-text]
67. Effect of age, ethnicity, and glucocorticoid use on tacrolimus pharmacokinetics in pediatric renal transplant patients.
    Pediatr Transplant, 9(2): 162-9. [Abstract] [Full-text]
68. Current status of ABO-incompatible kidney transplantation in children.
    Pediatr Transplant, 9(2): 148-54. [Abstract] [Full-text]
69. Anti-HLA class II antibodies in kidney retransplant patients.
    Tissue Antigens, 65(4): 370-8. [Abstract] [Full-text]
70. Early selection of a new UL97 mutant with a severe defect of ganciclovir phosphorylation after valaciclovir prophylaxis and short-term ganciclovir therapy in a renal transplant recipient.
    Antimicrob Agents Chemother, 49(4): 1580-3. [Abstract] [Full-text]
71. Factors accelerating liver fibrosis progression in renal transplant patients receiving ribavirin monotherapy for chronic hepatitis C.
    J Med Virol, 76(1): 61-8. [Abstract] [Full-text]
72. Monitoring low cytomegalovirus viremia in transplanted patients by a real-time PCR on plasma.
    J Med Virol, 76(1): 76-81. [Abstract] [Full-text]
73. Comparison of laparoscopic and open donor nephrectomy: a randomized controlled trial.
    BJU Int, 95(6): 851-5. [Abstract] [Full-text]
74. Follow-up of 28 HCMV seropositive renal-transplant recipients: comparison of clinical, biological and virological parameters in the groups of treated versus untreated infected patients.
    J Clin Virol, 33(1): 35-42. [Abstract] [Full-text]
75. Factors predicting long-term graft survival after kidney transplantation: multicenter study in Japan.
    World J Surg, 29(2): 249-56. [Abstract] [Full-text]
76. Sirolimus for Kaposi's sarcoma in renal-transplant recipients.
    N Engl J Med, 352(13): 1317-23. [Abstract] [Full-text]
77. Papillary renal cell carcinoma in allograft kidney.
    Eur Radiol, 15(4): 661-5. [Abstract] [Full-text]

© 2004-2008 Kidney Transplant Research Today. All Rights Reserved.